| Dr Marni Jae Sanders, MD | |
|
1 Hollow Ln Ste 315, New Hyde Park, NY 11042-1215 | |
| (516) 437-4300 | |
| (516) 437-2033 |
| Full Name | Dr Marni Jae Sanders |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 26 Years |
| Location | 1 Hollow Ln Ste 315, New Hyde Park, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215933304 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 215779 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Shore University Hospital | Manhasset, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Women For Women Obstetrics And Gynecology Llc | 6305996075 | 7 |
News Archive
Studying a new type of pinhead-size, lab-grown brain made with technology first suggested by three high school students, Johns Hopkins researchers have confirmed a key way in which Zika virus causes microcephaly and other damage in fetal brains: by infecting specialized stem cells that build its outer layer, the cortex.
Today, Lundbeck Inc. presented positive data from its pivotal phase III study to determine the efficacy and safety profiles of the investigational compound clobazam as adjunctive therapy in treating seizures associated with Lennox-Gastaut syndrome.
Researchers at the Institute of Bioengineering and Nanotechnology have developed a simple method of organizing cells and their microenvironments in hydrogel fibers. Their unique technology provides a feasible template for assembling complex structures, such as liver and fat tissues, as described in their recent publication in Nature Communications.
Alkermes, Inc. today announced preliminary results from a phase 2 clinical study of ALKS 33, one of Alkermes' proprietary candidates for the treatment of reward disorders and other central nervous system (CNS) disorders. The 12-week study was designed to assess the safety and efficacy of daily oral administration of three different dose levels of ALKS 33 compared to placebo in 400 alcohol dependent patients.
Glenmark Generics Inc. USA, the subsidiary of Glenmark Generics Limited, has been granted final approval for its abbreviated new drug application (ANDA) from the United States Food and Drug Administration for Omeprazole Delayed Release Capsules, their generic version of Prilosec by AstraZeneca.
› Verified 4 days ago
| Entity Name | Women For Women Obstetrics & Gynecology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376670661 PECOS PAC ID: 6305996075 Enrollment ID: O20090618000398 |
News Archive
Studying a new type of pinhead-size, lab-grown brain made with technology first suggested by three high school students, Johns Hopkins researchers have confirmed a key way in which Zika virus causes microcephaly and other damage in fetal brains: by infecting specialized stem cells that build its outer layer, the cortex.
Today, Lundbeck Inc. presented positive data from its pivotal phase III study to determine the efficacy and safety profiles of the investigational compound clobazam as adjunctive therapy in treating seizures associated with Lennox-Gastaut syndrome.
Researchers at the Institute of Bioengineering and Nanotechnology have developed a simple method of organizing cells and their microenvironments in hydrogel fibers. Their unique technology provides a feasible template for assembling complex structures, such as liver and fat tissues, as described in their recent publication in Nature Communications.
Alkermes, Inc. today announced preliminary results from a phase 2 clinical study of ALKS 33, one of Alkermes' proprietary candidates for the treatment of reward disorders and other central nervous system (CNS) disorders. The 12-week study was designed to assess the safety and efficacy of daily oral administration of three different dose levels of ALKS 33 compared to placebo in 400 alcohol dependent patients.
Glenmark Generics Inc. USA, the subsidiary of Glenmark Generics Limited, has been granted final approval for its abbreviated new drug application (ANDA) from the United States Food and Drug Administration for Omeprazole Delayed Release Capsules, their generic version of Prilosec by AstraZeneca.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marni Jae Sanders, MD 1 Hollow Ln Ste 315, New Hyde Park, NY 11042-1215 Ph: (516) 437-4300 | Dr Marni Jae Sanders, MD 1 Hollow Ln Ste 315, New Hyde Park, NY 11042-1215 Ph: (516) 437-4300 |
News Archive
Studying a new type of pinhead-size, lab-grown brain made with technology first suggested by three high school students, Johns Hopkins researchers have confirmed a key way in which Zika virus causes microcephaly and other damage in fetal brains: by infecting specialized stem cells that build its outer layer, the cortex.
Today, Lundbeck Inc. presented positive data from its pivotal phase III study to determine the efficacy and safety profiles of the investigational compound clobazam as adjunctive therapy in treating seizures associated with Lennox-Gastaut syndrome.
Researchers at the Institute of Bioengineering and Nanotechnology have developed a simple method of organizing cells and their microenvironments in hydrogel fibers. Their unique technology provides a feasible template for assembling complex structures, such as liver and fat tissues, as described in their recent publication in Nature Communications.
Alkermes, Inc. today announced preliminary results from a phase 2 clinical study of ALKS 33, one of Alkermes' proprietary candidates for the treatment of reward disorders and other central nervous system (CNS) disorders. The 12-week study was designed to assess the safety and efficacy of daily oral administration of three different dose levels of ALKS 33 compared to placebo in 400 alcohol dependent patients.
Glenmark Generics Inc. USA, the subsidiary of Glenmark Generics Limited, has been granted final approval for its abbreviated new drug application (ANDA) from the United States Food and Drug Administration for Omeprazole Delayed Release Capsules, their generic version of Prilosec by AstraZeneca.
› Verified 4 days ago
Natalie Meirowitz, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 27005 76th Ave, New Hyde Park, NY 11040 Phone: 718-470-7660 | |
Rajeevi Madankumar, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 270-5, 76th Ave, Suite T 457 A, New Hyde Park, NY 11040 Phone: 718-470-5468 | |
Aaron Davidson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2 Ohio Dr, New Hyde Park, NY 11042 Phone: 516-608-6800 | |
Charles Bruno, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2001 Marcus Ave Ste S265, New Hyde Park, NY 11042 Phone: 516-686-0500 | |
Noah D Kauff, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1111 Marcus Ave, New Hyde Park, NY 11042 Phone: 516-321-2241 | |
Martina Frandina, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2800 Marcus Ave, Room 204, New Hyde Park, NY 11042 Phone: 516-437-2020 Fax: 516-437-2019 | |
Dr. Evan Bruce Shapiro, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1300 Union Tpke Ste 206, New Hyde Park, NY 11040 Phone: 516-208-7600 Fax: 516-519-8818 |